Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus for endogenous intermediate and posterior uveitis
2006-004876-10Phase 2Terminated
- Sponsor
- Augenklinik am St. Franziskus-Hospital Münster
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of everolimus in uveitis, sponsored by Augenklinik am St. Franziskus-Hospital Münster. Primary endpoint: Inflammatory quiescence at 12 months. Started Apr 2007; status: terminated.
02
Drugs
everolimus
03
Conditions
uveitis
Beyond the preview
Go deeper on 2006-004876-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004876-10.